Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.

scientific article published on 17 October 2016

Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10286-016-0383-5
P932PMC publication ID5292083
P698PubMed publication ID27752785

P50authorDavid FridmanQ41838282
José-Alberto PalmaQ42336424
Christy L SpalinkQ114716369
Horacio KaufmannQ33278527
Lucy Norcliffe-KaufmannQ33278818
P2093author name stringJohn Papadopoulos
Diana Altshuler
Ryan C Dillon
P2860cites workThe Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patientsQ39635309
Dexmedetomidine: Are There Going to be Issues with Prolonged Administration?Q41680787
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS).Q44473697
Clonidine improves postprandial baroreflex control in familial dysautonomia.Q44597496
Perioperative use of dexmedetomidine in an infant with familial dysautonomia.Q45932290
Comparison of Intranasal Dexmedetomidine with Intranasal Clonidine as a Premedication in SurgeryQ47423708
Double-blind Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency DepartmentQ47435536
Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized ChildrenQ47657002
Intravenous labetolol in treating hypertensive crisis following dexmedetomidine infusion for procedural sedationQ48063503
Anesthetic management of renal transplantation in a patient with familial dysautonomiaQ48396624
Anesthetic management of a patient with familial dysautonomia for renal transplant surgeryQ48459237
Cyclic vomiting associated with excessive dopamine in Riley-day syndrome.Q50572086
Intranasal midazolam as a treatment of autonomic crisis in patients with familial dysautonomia.Q51419167
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomiaQ24536194
The effects of increasing plasma concentrations of dexmedetomidine in humansQ28141747
alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic roleQ28142296
Cerebral autoregulation and symptoms of orthostatic hypotension in familial dysautonomia.Q33167668
Current treatments in familial dysautonomiaQ34536321
Central autonomic dysfunction with defective lacrimation; report of five cases.Q34728985
Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndromeQ35868772
Intranasal Dexmedetomidine as a Sedative Premedication for Patients Undergoing Suspension Laryngoscopy: A Randomized Double-Blind StudyQ36022477
Increased frequency of rhabdomyolysis in familial dysautonomiaQ36132713
Dexmedetomidine: a novel sedative-analgesic agentQ36348758
Mother-induced hypertension in familial dysautonomiaQ36547368
Hyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa.Q36870156
Comparison of intranasal dexmedetomidine and dexmedetomidine-ketamine for premedication in pediatrics patients: A randomized double-blind studyQ36894677
Chewing-induced hypertension in afferent baroreflex failure: a sympathetic response?Q37357582
Rescue Sedation With Intranasal Dexmedetomidine for Pediatric Ophthalmic Examination After Chloral Hydrate Failure: A Randomized, Controlled TrialQ38392072
Familial dysautonomia: History, genotype, phenotype and translational researchQ38868944
P433issue1
P921main subjectdexmedetomidineQ412133
P304page(s)7-15
P577publication date2016-10-17
P1433published inClinical Autonomic ResearchQ15755245
P1476titleDexmedetomidine for refractory adrenergic crisis in familial dysautonomia
P478volume27

Reverse relations

Q47710474Intranasal dexmedetomidine for adrenergic crisis in familial dysautonomiacites workP2860

Search more.